Related Experiment Video
Updated: Oct 5, 2025

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Management and Outcomes of COVID - 19 Associated Cerebral Venous Sinus Thrombosis
Angel Miraclin T1, Dr Sanjith Aaron1, Ajith Sivadasan1
1Professor and Head, Department of Neurosciences, Christian Medical College, Vellore, Tamil Nadu 632004, India.
Insights
COVID-19 infection can present solely with cerebral venous thrombosis (CVT) symptoms. Prompt recognition and aggressive management, including decompressive hemicraniectomy, lead to excellent outcomes for COVID-19 associated CVT.
Area of Science:
- Neurology
- Infectious Diseases
- Vascular Medicine
Background:
- Systemic hypercoagulability and thrombosis are known complications of COVID-19.
- Cerebral venous thrombosis (CVT) is an increasingly reported, serious condition associated with COVID-19.
- The postulated mechanism involves viral activation of the endothelium, triggering coagulation pathways.
Purpose of the Study:
- To describe the clinical profile, investigations, and outcomes of patients with COVID-19 associated CVT.
- To compare COVID-19 associated CVT with non-COVID CVT cases.
Main Methods:
- A single-center prospective observational study was conducted in South India.
- Included patients aged over 18 years with concomitant COVID-19 infection and CVT.
- Clinical, laboratory, and imaging characteristics, management, and outcomes were documented and compared.
Main Results:
- 11% (11/97) of CVT cases were COVID-19 related during the pandemic's first two waves.
- 90% of COVID-19 CVT patients presented only with CVT symptoms, lacking respiratory signs.
- Headache (100%) and seizures (90%) were common; transverse sinus involvement (90%) and hemorrhagic venous infarction (90%) were frequent. Elevated inflammatory markers (D-dimer, CRP) were observed.
- All COVID-19 CVT patients survived, with 30% requiring decompressive hemicraniectomy; 6-month outcomes were excellent (mRS 0-2) and comparable to non-COVID CVT patients.
Conclusions:
- Cerebral venous thrombosis (CVT) symptoms can be the sole manifestation of COVID-19.
- Early diagnosis and aggressive management, including decompressive hemicraniectomy, are crucial for favorable outcomes in COVID-19 associated CVT.
Background:
Systemic hyper-coagulabilty leading to micro and macro thrombosis is a known complication of Coronavirus disease - 2019(COVID -19). The postulated mechanism appears to be the viral activation of endothelium, triggering the coagulation pathways. Thrombosis of the cerebral veins and sinuses (CVT), a potentially serious condition, has been increasingly reported with COVID - 19 infection. In this clinical study we attempt to describe the clinical profile, investigations and outcomes of patients with COVID- 19 associated CVT.
Methods:
This is a single center prospective observational study from South India. The study included patients (aged >18 years) with concomitant COVID infection and CVT. The clinical, laboratory, imaging characteristics, management and outcomes were described and compared with COVID negative CVT patients.
Results:
Out of 97 cases of CVT treated at our center during the first and second waves of the COVID pandemic 11/97 (11%) were COVID related CVT. Among these 11 patients, 9 (81%) had presented with only CVT related symptoms and signs and were tested positive for COVID - 19 infection during the pre-hospitalization screening. Respiratory symptoms were absent in 90% of the patients. Headache (100%) and seizures (90%) were the common presenting symptoms. The median time to diagnosis was 6 hours, from presentation to the emergency department. Transverse sinus was involved 10/11 (90%) and majority of them (9/11) had Haemorrhagic Venous Infarction (HVI). Acute inflammatory markers were elevated in comparison with non COVID CVT patients, with the mean serum D-dimer being 2462.75 ng/ml and the C-reactive protein was 64.5 mg/dl. Three patients (30%) underwent decompressive hemicraniectomy (DHC) because of large hemispheric HVI. All patients survived in the COVID CVT group while the mortality in the non COVID group was 4%. At 6 months follow up excellent outcome (modified Rankin Scale (mRS) score of 0-2) was noted equally in both groups.
Conclusions:
Symptoms and signs of CVT may be the only presentation of COVID-19 infection. Prompt recognition and aggressive medical management including DHC offers excellent outcomes.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Venous Thrombosis I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies

